Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:900904)

China · Delayed Price · Currency is CNY · Price in USD

0.4610

+0.0180 (4.06%)

At close: Jul 15, 2026

-8.89% (1Y)

Market Cap	2.56B -21.9%
Revenue (ttm)	1.90B -3.0%
Net Income	36.13M -42.1%
EPS	0.06 -47.9%
Shares Out	n/a
PE Ratio	70.74
Forward PE	n/a
Dividend	0.07 (2.27%)
Ex-Dividend Date	Jun 17, 2026

Volume	632,719
Open	0.4380
Previous Close	0.4430
Day's Range	0.4380 - 0.4830
52-Week Range	0.4030 - 0.5880
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:900904

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1990

Employees 1,196

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 900904

Financial Performance

In 2025, SHA:900904's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements